Steven E. Kahn

69.7k total citations · 21 hit papers
471 papers, 46.7k citations indexed

About

Steven E. Kahn is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Steven E. Kahn has authored 471 papers receiving a total of 46.7k indexed citations (citations by other indexed papers that have themselves been cited), including 257 papers in Endocrinology, Diabetes and Metabolism, 169 papers in Surgery and 136 papers in Molecular Biology. Recurrent topics in Steven E. Kahn's work include Pancreatic function and diabetes (137 papers), Metabolism, Diabetes, and Cancer (109 papers) and Diabetes Treatment and Management (103 papers). Steven E. Kahn is often cited by papers focused on Pancreatic function and diabetes (137 papers), Metabolism, Diabetes, and Cancer (109 papers) and Diabetes Treatment and Management (103 papers). Steven E. Kahn collaborates with scholars based in United States, United Kingdom and Canada. Steven E. Kahn's co-authors include Kristina M. Utzschneider, Rebecca L. Hull, Edward J. Boyko, Wilfred Y. Fujimoto, Michael W. Schwartz, Steven M. Haffner, Richard N. Bergman, Mark E. Cooper, Stefano Del Prato and Bernard Zinman and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Steven E. Kahn

458 papers receiving 45.3k citations

Hit Papers

Mechanisms linking obesity to insulin resistance and... 1993 2026 2004 2015 2006 2006 2003 2023 2003 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanisms linking obesity to insulin resistance and type 2 diabetes
    2006 4.0k citations Steven E. Kahn, Rebecca L. Hull et al. profile →
  2. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
    2006 2.2k citations Steven E. Kahn, Mark Heise et al. profile →
  3. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
    2003 1.6k citations Steven E. Kahn Diabetologia profile →
  4. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
    2023 1.3k citations Steven E. Kahn et al. profile →
  5. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
    2003 1.2k citations Kristina M. Utzschneider, Edward J. Boyko et al. Diabetologia profile →
  6. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
    2013 1.2k citations Steven E. Kahn, Mark E. Cooper et al. profile →
  7. Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function
    1993 1.2k citations Steven E. Kahn, Edward J. Boyko et al. Diabetes profile →
  8. Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity
    2004 978 citations Kristina M. Utzschneider, Steven E. Kahn et al. profile →
  9. Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome
    2004 758 citations Darcy B. Carr, Kristina M. Utzschneider et al. Diabetes profile →
  10. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
    2018 756 citations Julio Rosenstock, Vlado Perkovic et al. profile →
  11. The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
    2006 696 citations Kristina M. Utzschneider, Steven E. Kahn The Journal of Clinical Endocrinology & Metabolism profile →
  12. Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
    2008 583 citations Dana Dabelea, Steven E. Kahn et al. The Journal of Clinical Endocrinology & Metabolism profile →
  13. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
    2003 577 citations Mark A. Espeland, Karen Johnson et al. profile →
  14. The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
    2001 552 citations Steven E. Kahn The Journal of Clinical Endocrinology & Metabolism profile →
  15. Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
    2019 394 citations Julio Rosenstock, Steven E. Kahn et al. profile →
  16. COVID-19, Hyperglycemia, and New-Onset Diabetes
    2021 184 citations Steven E. Kahn et al. profile →
  17. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
    2024 123 citations Steven E. Kahn et al. profile →
  18. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
    2024 123 citations Steven E. Kahn et al. profile →
  19. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
    2023 120 citations Steven E. Kahn, Darren K. McGuire et al. profile →
  20. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
    2024 102 citations Steven E. Kahn et al. profile →
  21. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
    2024 100 citations Steven E. Kahn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. Kahn United States 105 21.1k 13.3k 12.9k 12.7k 9.2k 471 46.7k
Richard N. Bergman United States 99 16.1k 0.8× 12.2k 0.9× 9.3k 0.7× 10.9k 0.9× 7.1k 0.8× 623 42.3k
Ele Ferrannini Italy 107 29.1k 1.4× 11.9k 0.9× 13.3k 1.0× 15.2k 1.2× 8.1k 0.9× 535 51.5k
Markku Laakso Finland 117 23.4k 1.1× 13.5k 1.0× 11.7k 0.9× 16.3k 1.3× 9.8k 1.1× 673 58.2k
Ralph A. DeFronzo United States 88 19.4k 0.9× 11.9k 0.9× 8.1k 0.6× 13.5k 1.1× 6.9k 0.7× 284 38.6k
Ralph A. DeFronzo United States 113 24.6k 1.2× 17.7k 1.3× 12.0k 0.9× 21.0k 1.7× 9.1k 1.0× 427 52.3k
Takashi Kadowaki Japan 119 14.1k 0.7× 16.3k 1.2× 10.4k 0.8× 25.1k 2.0× 17.1k 1.9× 869 62.0k
Oluf Pedersen Denmark 92 12.9k 0.6× 11.7k 0.9× 9.4k 0.7× 18.3k 1.4× 5.1k 0.5× 707 43.8k
Richard E. Pratley United States 89 16.9k 0.8× 10.1k 0.8× 6.5k 0.5× 8.8k 0.7× 8.1k 0.9× 398 36.0k
Gerald M. Reaven United States 109 30.5k 1.4× 19.1k 1.4× 10.3k 0.8× 13.6k 1.1× 13.4k 1.5× 666 59.5k
Steven M. Haffner United States 125 33.2k 1.6× 11.4k 0.9× 11.1k 0.9× 11.2k 0.9× 14.5k 1.6× 518 62.2k

Countries citing papers authored by Steven E. Kahn

Since Specialization
Citations

This map shows the geographic impact of Steven E. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Kahn more than expected).

Fields of papers citing papers by Steven E. Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Kahn. The network helps show where Steven E. Kahn may publish in the future.

Co-authorship network of co-authors of Steven E. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Kahn. A scholar is included among the top collaborators of Steven E. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Kahn. Steven E. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akter, Rehana, Meghan F. Hogan, Nathalie Esser, et al.. (2025). Increased Steroidogenic Acute Regulatory Protein Contributes to Cholesterol-induced β-Cell Dysfunction. Endocrinology. 166(3).
2.
Palmer, Rebecca, Rebecca H. Neiberg, Kristen M. Beavers, et al.. (2025). Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort. Obesity. 33(3). 612–620. 1 indexed citations
3.
Perng, Wei, Shiyu Shu, David M. Nathan, et al.. (2025). Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study. Diabetologia. 69(1). 103–113.
4.
Contreras, Christopher, Lin Li, Michael A. Kalwat, et al.. (2024). RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes. Molecular Metabolism. 80. 101877–101877. 7 indexed citations
5.
6.
Li, Josephine H., Łukasz Szczerbiński, Mark Tripputi, et al.. (2023). 1466-P: Genome-Wide Association Studies in the GRADE Study Identify Genetic Variation Influencing the Response to Pharmacotherapy for Type 2 Diabetes. Diabetes. 72(Supplement_1). 1 indexed citations
7.
Song, Sun Ok, Seung Jin Han, Steven E. Kahn, et al.. (2020). Leptin and Adiponectin Concentrations Independently Predict Future Accumulation of Visceral Fat in Nondiabetic Japanese Americans. Obesity. 29(1). 233–239. 9 indexed citations
8.
Esser, Nathalie, Kristina M. Utzschneider, & Steven E. Kahn. (2020). Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. 63(10). 2007–2021. 108 indexed citations
9.
Templin, Andrew T., Mahnaz Mellati, Daniel T. Meier, et al.. (2020). Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro. Diabetologia. 63(11). 2385–2395. 11 indexed citations
10.
McGuire, Darren K., John H. Alexander, Odd Erik Johansen, et al.. (2019). Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 139(3). 351–361. 112 indexed citations
11.
Utzschneider, Kristina M., Andrea Mari, Mark Tripputi, et al.. (2019). 124-OR: Comparison of OGTT Model-Derived Measures of ß-Cell Function between Youth and Adults. Diabetes. 68(Supplement_1). 1 indexed citations
12.
Han, Seung Jin, Soo‐Kyung Kim, Wilfred Y. Fujimoto, et al.. (2017). Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes. Diabetes Research and Clinical Practice. 134. 131–138. 13 indexed citations
13.
Morton, Gregory J., Kenjiro Muta, Karl J. Kaiyala, et al.. (2017). Evidence That the Sympathetic Nervous System Elicits Rapid, Coordinated, and Reciprocal Adjustments of Insulin Secretion and Insulin Sensitivity During Cold Exposure. Diabetes. 66(4). 823–834. 41 indexed citations
14.
Mather, Kieren J., Christopher Christophi, Vanita R. Aroda, et al.. (2015). Steroid Sex Hormones, Sex Hormone–Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program. The Journal of Clinical Endocrinology & Metabolism. 100(10). 3778–3786. 50 indexed citations
15.
McCaffery, Jeanne M., George D. Papandonatos, Gordon S. Huggins, et al.. (2013). FTO predicts weight regain in the Look AHEAD clinical trial. International Journal of Obesity. 37(12). 1545–1552. 35 indexed citations
16.
Gujral, Unjali P., K.M. Venkat Narayan, Steven E. Kahn, & Alka M. Kanaya. (2013). The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: The MASALA study. Journal of Diabetes and its Complications. 28(1). 45–50. 40 indexed citations
17.
Utzschneider, Kristina M., Mirjam Faulenbach, Julia H. Goedecke, et al.. (2010). Insulin Resistance is the Best Predictor of the Metabolic Syndrome in Subjects With a First‐Degree Relative With Type 2 Diabetes. Obesity. 18(9). 1781–1787. 31 indexed citations
18.
Franks, Paul W., K. A. Jablonski, Linda M. Delahanty, et al.. (2009). Assessing gene–treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia. 52(7). 1456–1456. 1 indexed citations
19.
Holman, Rury R., et al.. (2003). Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study. Diabetologia. 46. 1 indexed citations
20.
Vesely, David L., Robert B. Sothern, Lawrence E. Scheving, et al.. (1996). Circadian relationships between circulating atrial natriuretic peptides and serum calcium and phosphate in healthy humans. Metabolism. 45(8). 1021–1028. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard N. Bergman Breakdown of academic impact, for papers by Ele Ferrannini Breakdown of academic impact, for papers by Markku Laakso Breakdown of academic impact, for papers by Ralph A. DeFronzo Breakdown of academic impact, for papers by Ralph A. DeFronzo Breakdown of academic impact, for papers by Takashi Kadowaki Breakdown of academic impact, for papers by Oluf Pedersen Breakdown of academic impact, for papers by Richard E. Pratley Breakdown of academic impact, for papers by Gerald M. Reaven Breakdown of academic impact, for papers by Steven M. Haffner
Rankless by CCL
2026